Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tuesdaynightridon Jun 19, 2014 7:59am

241 Views

Post# 22674183

RE:RE:Bladder Cancer Trials

Thanks, I do hope your right. Assuming that the start of trial is in 1st q 2015 (let's say March 30 to be conservative), then I we might expect interim on 5-10 enrollees by late Sept for tumor shrinkage.
i recall that 1 fast track criteria is that it must perform better than whats out there which is why the selection of bladder cancer is genious.

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles